#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Polymyositis Peripheral T-cell lymphoma unspecified Spinal muscular atrophy Hepatocellular carcinoma Retinal artery occlusion Hepatic cirrhosis Neurotrophic keratopathy Acute hepatic failure Acute leukaemia Meningococcal immunisation Renal cell carcinoma Chronic lymphocytic leukaemia refractory Fatty acid oxidation disorder Prolymphocytic leukaemia Amyotrophic lateral sclerosis More trials…

    Learn about Rare Diseases

    Lymphangioma Osteosarcoma recurrent – Treatment Hairy cell leukaemia – Diagnostics Prolymphocytic leukaemia – Diagnostics Fragile X syndrome – Diagnostics Lysosomal storage disorder Osteosarcoma – Life with Disease Cystic fibrosis lung – Basic Information Congenital hypotransferrinaemia – Diagnostics Anaplastic thyroid cancer – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Annamycin Nalbuphine Hydrochloride Nmd670 Evolocumab Argatroban Monohydrate Lenograstim Tocilizumab Rct2100 Azd0901 Deferiprone Micronised Spironolactone Mps-213 Molidustat Sodium Magnesium Chloride Naloxone Hydrochloride Esketamine Hydrochloride Phenylalanine Valine Benserazide Hydrochloride Taletrectinib More therapies…

    Learn about Your Condition

    Brain neoplasm malignant Alcohol abuse Hypomagnesaemia Crohn's disease Partial seizures Metastasis Primary amyloidosis Inclusion body myositis Hepatotoxicity Demyelination Endolymphatic hydrops Systemic mastocytosis Lymphangiosarcoma Nodular melanoma Metabolic disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Aconite Pain Oil to Prevent and Reduce Symptoms of Chemotherapy-Induced Polyneuropathy in Cancer Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Polyneuropathy
    Investigated Drugs:
    • D-Camphor
    • Lavender Oil
    • Taxanes
    Germany

  • Study on Sodium Thiosulfate to Prevent Hearing Loss in Patients with Head and Neck Cancer Receiving Cisplatin Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Sodium Thiosulfate
    The Netherlands

  • Study on Metamizole Sodium Monohydrate for Pain Relief in Patients with Chronic Pancreatitis Diagnosed Less Than 3 Years Ago

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pancreatitis chronic
    Investigated Drugs:
    • Metamizole Sodium Monohydrate
    The Netherlands

  • Study on Acetic Acid for Healing Skin Ulcers in Patients with Biofilm

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Skin ulcer
    Investigated Drugs:
    • Acetic Acid, Glacial
    Spain

  • Study on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polymyositis
    • Dermatomyositis
    Investigated Drugs:
    • Humanised Igg1K Monoclonal Antibody Against Interferon Beta
    • Proguanil Hydrochloride
    • Hydroxychloroquine Sulfate
    Belgium Bulgaria France Germany Hungary Italy +4

  • Study on Radiotherapy Alone or with Obinutuzumab for Patients with Early Stage Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Obinutuzumab
    Italy
Previous Page
1 … 539 540 541 542 543 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!